Battaglia, Alessandra
 Distribuzione geografica
Continente #
NA - Nord America 490
EU - Europa 453
AS - Asia 130
AF - Africa 2
OC - Oceania 2
Totale 1.077
Nazione #
US - Stati Uniti d'America 487
SE - Svezia 108
DE - Germania 106
IT - Italia 93
CN - Cina 68
FR - Francia 33
UA - Ucraina 32
IE - Irlanda 30
SG - Singapore 23
IN - India 16
RU - Federazione Russa 12
GB - Regno Unito 11
BE - Belgio 10
FI - Finlandia 7
HK - Hong Kong 5
TR - Turchia 5
CZ - Repubblica Ceca 4
BZ - Belize 3
IR - Iran 3
JP - Giappone 3
NL - Olanda 3
AU - Australia 2
CI - Costa d'Avorio 2
MN - Mongolia 2
NO - Norvegia 2
AT - Austria 1
HR - Croazia 1
IL - Israele 1
KR - Corea 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
VN - Vietnam 1
Totale 1.077
Città #
Chandler 133
Ashburn 32
Dublin 30
San Mateo 24
Ann Arbor 21
Dearborn 21
Nanjing 20
Jacksonville 19
Marseille 19
Singapore 18
Milan 12
Boston 11
Princeton 11
Fairfield 10
Scottsdale 10
Wilmington 10
New York 9
Woodbridge 8
Beijing 7
Brussels 7
Cattolica 6
Lawrence 6
Norwalk 6
Rome 6
Cambridge 5
Changsha 5
Moscow 5
Nürnberg 5
Bremen 4
Catania 4
Hong Kong 4
Leawood 4
Los Angeles 4
Mountain View 4
Naples 4
Redwood City 4
San Giovanni la Punta 4
Seattle 4
Belize City 3
Cagliari 3
Izmir 3
Kunming 3
Lake Forest 3
Lanzhou 3
Redmond 3
Abidjan 2
Boardman 2
Bologna 2
Ferrara 2
Fremont 2
Hangzhou 2
Hebei 2
Houston 2
London 2
Negrar 2
Palermo 2
Pavia 2
Perth 2
Pisa 2
Pune 2
University Park 2
Verona 2
Waanrode 2
Almaty 1
Ancona 1
Boydton 1
Brno 1
Buffalo 1
Busto Arsizio 1
Casaletto 1
Castenaso 1
Changchun 1
Clearwater 1
Cormeilles-en-Parisis 1
Cutigliano 1
Dong Ket 1
Edinburgh 1
Foggia 1
Formia 1
Groningen 1
Hefei 1
Helsinki 1
Istanbul 1
Jerusalem 1
Jiaxing 1
Kemerovo 1
Kish 1
Kocaeli 1
La Canada Flintridge 1
Lancaster 1
Landshut 1
Las Vegas 1
Lucca 1
Madison 1
Marigliano 1
Mumbai 1
Nanchang 1
Napoli 1
New Bedfont 1
Newham 1
Totale 610
Nome #
The human microglial HMC3 cell line: where do we stand? A systematic literature review 158
Thymopoiesis, regulatory T cells, and TCRVbeta expression in thymoma with and without myasthenia gravis, and modulatory effects of steroid therapy 131
Collagen-specific T cell repertoire in blood and synovial fluid varies with disease activity in Early Rheumatoid Arthritis. 124
Doppler velocimetry and cytofluorimetric analysis in uterine myomas. 75
Comment on "Cutting edge: human CD4-CD8- thymocytes express FOXP3 in the absence of a TCR". 71
Immunological changes in the ascites of cancer patients after intraperitoneal administration of the bispecific antibody catumaxomab (anti-EpCAM x anti-CD3) 63
A combined ANXA2-NDRG1-STAT1 gene signature predicts response to chemoradiotherapy in cervical cancer 60
Identification and antitumor activity of a novel inhibitor of the NIMA-related kinase NEK6 53
Preoperative Anti-Class III β-Tubulin Antibodies As Relevant Clinical Biomarkers in Ovarian Cancer 51
A robust immune system conditions the response to abagovomab (anti-idiotypic monoclonal antibody mimicking the CA125 protein) vaccination in ovarian cancer patients 45
Pd-l1 expression on circulating tumour-derived microvesicles as a complementary tool for stratification of high-grade serous ovarian cancer patients 44
Translational immune correlates of indirect antibody immunization in a randomized phase II study using scheduled combination therapy with carboplatin/paclitaxel plus oregovomab in ovarian cancer patients 38
Measuring extracellular vesicles by conventional flow cytometry: Dream or reality? 38
Interleukin-21 (IL-21) synergizes with IL-2 to enhance T-cell receptor-induced human T-cell proliferation and counteracts IL-2/transforming growth factor-beta-induced regulatory T-cell development 33
Hyaluronic acid-paclitaxel: effects of intraperitoneal administration against CD44(+) human ovarian cancer xenografts. 32
Anti-tumor necrosis factor α therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis 31
Stat1 confers sensitivity to radiation in cervical cancer cells by controlling Parp1 levels: a new perspective for Parp1 inhibition 25
The BET Inhibitor OTX015 Exhibits In Vitro and In Vivo Antitumor Activity in Pediatric Ependymoma Stem Cell Models 19
Lymphocyte activation associated antigens 10
Totale 1.101
Categoria #
all - tutte 5.155
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.155


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020140 33 1 6 11 10 15 21 4 3 7 19 10
2020/202177 3 6 0 7 8 3 11 1 13 5 15 5
2021/2022161 12 9 4 13 7 6 7 23 14 8 28 30
2022/2023370 49 54 19 63 21 44 29 28 43 4 9 7
2023/2024187 5 49 5 5 6 19 13 2 7 16 34 26
2024/20255 5 0 0 0 0 0 0 0 0 0 0 0
Totale 1.101